A Turnaround Story for 2026!
Decreasing concerns and a stronger focus on innovations could contribute to regaining investor confidence!
Debt reduction is likely to favor profitability improvements. The P/E ratio of around 9.5 appears moderate!
Reading Time: 1 minute
In the last approximately two months, Bayer AG has experienced a dynamic price rally. The driving factors behind the price movements were a combination of legal news and operational restructuring. Recently, there was a potentially landmark development with the US Supreme Court agreeing to review a significant glyphosate case. Investors are hopeful that a ruling (based on the supremacy of US federal law) might put an end to the numerous individual lawsuits. This could drastically reduce or cap the biggest risk that weighed on the stock price –...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
